3//SEC Filing
Brookside Capital Trading Fund, L.P. 3
Accession 0001181431-14-005057
CIK 0001399529other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:25 PM ET
Size
10.5 KB
Accession
0001181431-14-005057
Insider Transaction Report
Form 3
BROOKSIDE CAPITAL INVESTORS L P
10% Owner
Holdings
- 2,337,000(indirect: See Footnote)
Common Stock
Brookside Capital Investors II, L.P.
10% Owner
Holdings
- 2,337,000(indirect: See Footnote)
Common Stock
Brookside Capital Trading Fund, L.P.
10% Owner
Holdings
- 2,337,000(indirect: See Footnote)
Common Stock
BROOKSIDE CAPITAL MANAGEMENT LLC
10% Owner
Holdings
- 2,337,000(indirect: See Footnote)
Common Stock
BROOKSIDE CAPITAL PARTNERS FUND LP
10% Owner
Holdings
- 2,337,000(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]Brookside Capital Management, LLC ("BCM") is the sole general partner of Brookside Capital Investors, L.P. ("BCI") and Brookside Capital Investors II, L.P. ("BCI II"). BCI is the sole general partner of Brookside Capital Partners Fund, L.P. ("BCPF") and BCI II is the sole general partner of Brookside Capital Trading Fund, L.P ("BCTF"). BCM, BCI and BCI II each may be deemed to share voting dispositive powers with respect to the shares held by each BCPF and BCTF. Each of BCM, BCI and BCI II disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001461875
Filing Metadata
- Form type
- 3
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 6:25 PM ET
- Size
- 10.5 KB